Viewing Study NCT04416568


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-24 @ 6:29 PM
Study NCT ID: NCT04416568
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2020-06-02
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Sponsor: Dana-Farber Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-08-14
Start Date Type: ACTUAL
Primary Completion Date: 2025-07-17
Primary Completion Date Type: ACTUAL
Completion Date: 2026-06
Completion Date Type: ESTIMATED
First Submit Date: 2020-06-02
First Submit QC Date: None
Study First Post Date: 2020-06-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-15
Last Update Post Date: 2025-12-17
Last Update Post Date Type: ESTIMATED